Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Pharmidex Pharmaceutical Services

Pharmidex Pharmaceutical Services is listed as a small business research supplier in the Scientist.com network, with 2 sites in 1 country and 1 service area.

View Pharmidex Pharmaceutical Services on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 2
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Animal Science and Welfare Audits

  • Vivarium Support Source procurement, housing, husbandry, and care of laboratory animals as well as designing, building and managing vivarium facilities.

Bioimaging

  • Bioimaging Visualize biological process non-invasively in real time.
  • In Vivo Imaging In-vivo imaging using PET, MRI, CT etc.
  • In Vivo Whole Tissue and Animal Imaging Visualize, analyze and track light producing reporters in whole animals.
  • In Vivo Whole Tissue and Animal Imaging Analysis Analysis of images from in vivo studies produced using PET, MRI, CT, etc. in a variety of species.

Biomarkers

  • Biomarker Services Evaluating normal/abnormal biological conditions and characteristics within the body
  • Cerebrospinal Fluid Analysis Use CSF to detect or monitor a variety of nervous system diseases or conditions.
  • Cytokine Release Assay Use in vivo or in vitro assays to detect unregulated or excessive release of pro-inflammatory cytokines.
  • Hematoxylin & Eosin (H&E) Staining Visualize microscopic structures in cells or tissues.
  • Histopathology Evaluate slide preparation of cells or tissues for abnormal features.
  • Immunostaining Use labeled antibodies to detect proteins or other antigens in cells or tissues.
Show all 13 in Biomarkers 7 more
  • In Vivo Apoptosis Detection Visualize and quantify apoptosis in real time.
  • Metabolomics Biomarker Discovery Identify and quantitate metabolite biomarkers in blood, urine, CSF and bodily fluids.
  • Paraffin-based Histology Perform sectioning and histological analysis of wax-embedded samples.
  • Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
  • Plaque Assays Determine infectious viral titer using plaque-forming units or purify viral stocks.
  • Protein Bioanalysis Quantitative measurement of xenobiotics (drugs and their metabolites, and biological molecules in unnatural locations or concentrations) and Proteins in biological systems
  • Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.

Cell Culture and Characterization

  • Cell and Tissue Histology Prepare and stain frozen, fixed and embedded (FFPE) tissue samples.
  • Cryo-based Histology Perform sectioning and histological analysis of frozen non-fixed samples.
  • Histology Examine by microscopy the anatomy of cells and tissues of clinical patients and animal models.
  • Resin-based Histology Perform sectioning and histological analysis of epoxy/acrylic/polycarbonate-embedded samples.
  • Trichrome Staining Use a variety of techniques for the selective visualization of muscle, collagen fibers, fibrin and erythrocytes.
Show all 234 services 218 more

Chemical and Compound Analysis

  • GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
  • MALDI-TOF Analysis Use mass spectrometry technique to analyze compound, biomolecules and large organic molecules.
  • NMR Methods Use nuclear magnetic resonance spectroscopy to identify drug intermediates.
  • Non GLP Large Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of large biomolecules.
  • Non GLP Small Molecule Bioanalysis Detect and analyze the pharmacokinetic profile of small molecules.
Show all 9 in Chemical and Compound Analysis 3 more
  • Protein Binding HPLC Uses high pressure liquid chromatography to separate protein-drug complexes.
  • Sample Bioanalysis Determination of concentration of an analyte in biological sample.
  • Solubility Studies Analyze substances for kinetics of solubility using nephelometry and UV-Vis spectrometry.

Chemical and Compound Testing

  • Clinical Pathology Diagnose disease based on the laboratory analysis of bodily fluids, such as blood, urine and tissues.

Chemistry, Manufacturing and Controls (CMC)

  • Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services
  • Drug Formulation Combine substances including the active drug into a final product with the desired metabolic and therapeutic properties.
  • GMP Synthesis Synthesize APIs including small molecules, formulations and protein-based drugs under GMP compliance.
  • ICH-compliant stability testing Perform ICH-compliant stability testing

Clinical Trials

  • Bioequivalence Studies Assess the expected biological equivalence of two proprietary preparations of a drug.
  • Pharmacokinetic Studies Design a study that observes the time course of drug absorption, distribution, metabolism, and excretion, as means to test the safety and effective therapeutic management of drugs in an individual patient.

Data Science/Bioinformatics

  • Discovery In Silico Drug Dynamics Develop In Silico model of a drug candidate with a biological system with applications such as Pro-drug Predictions, ADME-PK Due Diligence, Brain-Barrier Permeability Simulation, Drug Absorption Simulation, In Silico...

Discovery Chemistry

  • Compound Docking Identify potential compound hits based on the 3D structure of a target protein.
  • Discovery Computational Chemistry Model the interaction of a drug candidate with protein targets such as kinases, GPCRs, receptors, ion channels or enzymes.
  • LCMS Analysis Physically separate substances using liquid chromatography and mass spectrometry.
  • Pharmacophore Modeling Use computer models to identify hits based on structural similarity to known active compounds.

Disease Models

  • Atopic Dermatitis Models Measure therapeutic endpoints in animal models of atopic dermatitis.
  • Autoimmune Models Measure therapeutic endpoints in animal models with autoimmune disorders.
  • Behavioral Testing Models Investigate sensory-motor and emotional functions, social behavior and day-night activity.
  • Blood Models Test for therapeutic efficacy of drug candidates in blood disorder models.
  • Cardiovascular Metabolics Models Measure therapeutic endpoints in animal models of cardiovascular disorders.
  • Cardiovascular Models Test the therapeutic efficacy of drug candidates in cardiovacular disease models.
Show all 34 in Disease Models 28 more
  • Cognition Models Measure therapeutic endpoints in animal models of cognition.
  • Comparative Pharmacology Compare drug responses across species for improved reliability in translational studies.
  • Cough Models Test the therapeutic efficacy of drug candidates in cough models.
  • Dermatology Models Measure therapeutic endpoints in animal models of dermatological disorders.
  • Hair Growth Models Measure dermal histology, skin thickness, % anagen induction, hair proliferation and other hair growth markers.
  • In Vivo Physiologic Monitoring Monitor and collect data from conscious, freely moving laboratory animals.
  • In Vivo Technologies Models Carry out EEGs, cognition assessment, microdialysis, electrophysiology, MRI, ultrasound and tomographic analysis.
  • Infectious Disease Models Test therapeutic efficacy of drug candidate in infectious disease model.
  • Inflammation Models Measure therapeutic endpoints in animal models for inflammation.
  • Inflammatory Bowel Disease Models Measure IBD symptom severity, cytokine levels and body weight, and evaluate IHC and Ariol images.
  • Inflammatory Pain Models Measure therapeutic endpoints in animal models of inflammatory pain.
  • Ischemia Models Measure therapeutic endpoints in animal models of ischemia.
  • LPS Acute Response Models Measure therapeutic endpoints in acute models of inflammation.
  • LPS Lung Inflammation Models Measure therapeutic endpoints in animal models of inflammation.
  • Microdialysis Models Measure the effect of drug candidates on neurotransmission in rat or mouse models.
  • Microsurgery in Rodents Outsource microsurgeries projects required for testing new therapies on a rodent model.
  • Neuroscience Models Test therapeutic efficacy of drug candidate in neurological disease model.
  • Ob/ob Mouse Use a single animal species to create one or more disease models obesity and angiogenesis.
  • Object Recognition Measure spatial navigation, working memory and cognitive function in animal models.
  • OVA Lung Inflammation Models Measure therapeutic endpoints in animal models of inflammation.
  • Pain Models Test therapeutic efficacy of drug candidate in pain model.
  • Parkinson's Disease Models Measure therapeutic endpoints in animal models of Parkinson's disease.
  • Pulmonary Fibrosis Models Measure therapeutic endpoints in animal models of pulmonary fibrosis.
  • Receptor Binding Models Measure the binding and distribution of drugs and biologics in animal tissues.
  • Respiratory Models Test therapeutic efficacy of drug candidate in respiratory disease model.
  • Schizophrenia Models Measure therapeutic endpoints in animal models of schizophrenia.
  • Stroke Models Measure therapeutic endpoints in animal models of stroke.
  • Viral Infection Models Measure therapeutic endpoints in animal models of viral infection.

General in vivo Toxicology

  • Carcinogenicity Study - Mouse Conduct a repeat dose, chronic carcinogenicity study in mice to determine the tendency of your compound to produce tumors.
  • Carcinogenicity Study - Rat Conduct a repeat dose, chronic carcinogenicity study in rats to determine the tendency of your compound to produce tumors.
  • Dose Range Finding Study - Mouse Conduct a study to determine the dose range of your compound in mice.
  • Dose Range Finding Study - Rat Conduct a study to determine the dose range of your compound in rats.
  • General Toxicology Use in vivo models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.
  • IV Toxicology Test the toxicological effect of IV delivery of drug candidate.
Show all 14 in General in vivo Toxicology 8 more
  • Nonclinical Study Monitoring Provide nonclinical study monitors throughout the US and Canada to monitor in vivo and in vitro studies are CROs
  • Oral Toxicology Use toxicity studies in animals to evaluate the oral toxicity of a drug candidate.
  • Repeat Dose Toxicity Study - Mouse Conduct a repeat dose study in mice to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Other Species Conduct a repeat dose study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Toxicity Study - Rat Conduct a repeat dose study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Single Dose Acute Toxicity Study - Mouse Conduct a single dose study in Mice and Murines to determine the toxicokinetic behavior of your compound.
  • Single Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by a single administration in a 7 day period.
  • Single Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by a single administration in a 7 day period.

In Vitro ADME

  • Blood Brain Barrier Measure movement of drugs from circulating blood to brain extracellular fluid.
  • Caco-2 Cell Permeability Measure passive diffusion of drugs across Caco2 cell monolayers.
  • Cell Fractionation Isolate organelles and subcellular components.
  • Compound Distribution Determine the metabolic fate of a drug candidate in tissue and organs of diseased and normal animal models.
  • Conjugate Detection Measure the conjugation of endogenous small molecules to drug candidates after in vivo administration.
  • CYP Induction Detect increases in the expression of various isoforms of cytochrome P450 (CYP450).
Show all 41 in In Vitro ADME 35 more
  • CYP Inhibition Assay Assess the inactivation and inhibition of cytochrome P450 (CYP450) in microsomes isolated from primary human hepatocytes or liver.
  • CYP Isozyme Mapping Determine the isozymes of cytochrome P450 (CYP450) involved in the metabolism of a drug candidate.
  • Cytochrome P450s Assess the inhibition or induction of the various isozymes of cytochrome P450s by drug candidates.
  • Drug Distribution Studies Determine the metabolic fate of compounds within tissues, organs and plasma.
  • Drug Drug Interactions Determine whether a substance affects the activity of a drug when both are administered together.
  • GI Fluid Stability Determine dosing and turnover of drug candidates in gastrointestinal fluids.
  • HT ADME (High-Throughput Absorption, Distribution, Metabolism and Excretion) Analyze the process and effects of a chemical that is ingested by an organism using an advanced technological screening process. Use for drug...
  • In Vitro ADME in Vitro ADME services
  • Intestinal Permeability Use Caco 2 and MCDK cells to assess mono-directional drug transport by passive diffusion in culture.
  • Isotopic Labeling Track labeled isotopes through a metabolic pathway or cell by measuring mass, vibrational mode or radioactive decay.
  • Membrane Transporters Use Caco 2 cells to assess bi-directional drug transport in the presence or absence of P-glycoprotein (P-gp) inhibitors.
  • Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
  • Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
  • Metabolic Stability in Microsomes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver microsomes.
  • Metabolite Generation Analyze the formation of drug metabolites after administration of drug to an animal model or patient.
  • Metabolite Identification Identify drug metabolites that are formed after administration of drug to an animal model or patient.
  • Metabolite Identification and Profiling Estimate drug candidate metabolites after administration of drug to an animal or human subject.
  • Metabolite Quantification Quantify drug metabolites formed after drug administration to an animal model or patient.
  • Metabolite Structural Elucidation Use analytical tools to characterize metabolite structure.
  • Metabolite Synthesis Synthesize drug metabolites that are formed after administration of drug to an animal model or patient.
  • Multidrug Resistance Identify potential causes of drug-drug interactions.
  • Nasal Permeability Test for passive diffusion and active transport in nasal permeability models.
  • No Label Methods Use mass spectrometry to detect and identify non-radiolabeled drug intermediates in pre-clinical samples.
  • Non Isotopic Labeling Track unlabeled macromolecules through a metabolic pathway or cell.
  • Ocular Permeability Measure passive diffusion and active transport of drugs across confluent ocular epithelial cells.
  • PharmacoScan - A Pharmacogenomics Tool Understand how genetic variation affects drug absorption, distribution, metabolism, and excretion (ADME) in a microarray plate.
  • Phase I Metabolism Use enzymes such as cytochrome P450 oxidases to introduce reactive or polar groups into xenobiotics.
  • Phase II Metabolism Use transferase enzymes such as glutathione S-transferases to conjugate phase I xenobiotics to polar compounds.
  • Plasma Stability Assay Determine degradation rate of drug candidates in plasma.
  • Protein Binding Ultrafiltration Measure the rate at which unbound drug passes through a dialysis membrane that models epithelial barrier pore size.
  • Radiolabeled Tracers Use radiolabeled drug metabolites as radiotracers for measuring desired physiological processes.
  • Reactive Metabolite Ensure that your drug candidate is not generating toxic reactive metabolites in vivo.
  • Red Blood Cell (RBC) Partitioning (Blood/Plasma Ratio) Measure the distribution of a compound between red blood cells and plasma.
  • Reference Standards Find reference standards for assays, tests and services.
  • Skin Permeability Use human skin models to determine transdermal delivery and percutaneous absorption of pre-clinical drugs.

In Vitro Assays

  • In Vitro Assay Development Develop innovative assay and screening methods outside a living organism to enable a wide range of pre-clinical activities.
  • Inflammation Assays Identify and validate pro- and anti-inflammatory molecules, recruitment inhibitors and chemotaxis modulators.

In Vitro Pharmacology

  • In Vitro Disease Models Screen pre-clinical candidates without the use of live animals.
  • In Vitro Hemolysis Assay Evaluate the toxicity of a drug, metabolite or excipient by hemolytic release of hemoglobin in the plasma.
  • In Vitro Oncology Models Use cell-based and biochemical models of cancer.

In Vitro Toxicology

  • Cytotoxicity Test for effects on cell viability and proliferation
  • Epidermal Cell Toxicity Measure toxicity by quantifying the number of live/dead cells, cell membrane integrity and glutathione (GSH) levels.
  • Hepatocyte Toxicity Assess the cytotoxic effects of pre-clinical compounds on hepatocytes purified from patients and animal models.

In Vivo ADME

  • Absorption studies Study the factors determning how efficiently a compound may enter the bloodstream.
  • Chronic Bile Duct Cannulation (BDC) Study - Other Species Conduct a bile duct cannulation (BDC) study in other species to support the absorption, distribution, metabolism and excretion profiling of your compound.
  • Chronic Bile Duct Cannulation (BDC) Study - Rat Conduct a bile duct cannulation (BDC) study in rats to support the absorption, distribution, metabolism and excretion profiling of your compound.
  • Ocular Distribution Study - Other Species Conduct a study to determine the distribution of your compound in ocular tissues of other species.
  • Ocular Distribution Study - Rabbit Conduct a study to determine the distribution of your compound in ocular tissues of the rabbit.
  • Ocular Distribution Study - Rat Conduct a study to determine the distribution of your compound in ocular tissues of the rat.
Show all 8 in In Vivo ADME 2 more
  • Placental Transfer Study - Other Species Conduct a study to determine the extent of placental transfer in other species by assessing the radioactivity of your compound in fetal tissue and maternal blood.
  • Tissue Distribution Study the tissues in which a compound or its metabolites, accumulate.

In Vivo Pharmacokinetics

  • In Vivo Pharmacokinetics Run pharmacokinetic studies in animals that measure a drug's absorption, distribution, metabolism and excretion (ADME).
  • In Vivo PK Consulting Expert advice on pharmacokinetics and how specific drugs affect the body to determine function, effectiveness, dosage size, etc…
  • Integrated In Vivo Services Package Process an entire In Vivo Project including: Dose Formulation, PK Screening, ADME-Profiling, Toxicology, Safety Pharmacology, DART, IND Filing from our bundle of suppliers.
  • Mass Balance Elucidate excretory pathways and organ distribution of a parent drug and metabolites
  • Maximum Tolerated Dose (MTD) Studies Determine Maximum Tolerated Dose (MTD) of a drug candidate in either a single or repetitive dosing study in a rodent (typically mouse or rat).
  • Ocular Pharmacokinetic (PK) Screening - Other Species Conduct a pharmacokinetic screening study in other species that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
Show all 18 in In Vivo Pharmacokinetics 12 more
  • Ocular Pharmacokinetic (PK) Screening - Rabbit Conduct a pharmacokinetic screening study in rabbits that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Ocular Pharmacokinetic (PK) Screening - Rat Conduct a pharmacokinetic screening study in rats that measures the absorption, distribution, metabolism and excretion of your compound following ocular administration.
  • Pharmacokinetic (PK) Screening Measure the absorption, distribution, metabolism and excretion of a compound.
  • Pharmacokinetic (PK) Screening - Dog / Canine Run pharmacokinetic studies in dogs that measure a drug’s absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Monkey / Non-human Primate Conduct a pharmacokinetic screening study in monkeys/non-human primates that measures the absorption, distribution, metabolism and excretion of your compound.
  • Pharmacokinetic (PK) Screening - Mouse Run pharmacokinetic studies in mice that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Other Species Run pharmacokinetic studies in large animals that measure a drug's absorption, distribution, metabolism and excretion.
  • Pharmacokinetic (PK) Screening - Rat Run pharmacokinetic studies in rats that measure a drug's absorption, distribution, metabolism and excretion.
  • Rat Efficacy Combination Use rat models to determine the anti-cancer efficacy and potential synergy of a drug candidate with a standard drug treatment.
  • Rat Efficacy Monotherapy Use rat models to determine the anti-cancer efficacy of a drug candidate compared to a positive control.
  • Repetitive Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
  • Repetitive Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by repetitive administrations for 7 days.

Medical Communications

  • Pharmacodynamic/ Pharmacokinetic Reports Create Pharmacodynamic/ Pharmacokinetic reports to report to the appropriate regulatory bodies.
  • Toxicology Reports Create pre-clinical toxicology reports.

Model Development

  • Animal Model Development Create new systems for profiling pre-clinical therapeutics, devices, and surgical techniques.
  • Custom Model Development Develop a custom disease model.
  • In Silico PK-PD Modeling Quantitative modeling and simulations correlation of pharmacokinetic and pharmacodynamic endpoints in support of preclinical and clinical development.
  • NMRI Mouse Use a single animal species to create one or more disease models for cachexia and hemophilia.
  • PBMC Humanized Mice Study and evaluate compounds for infectious diseases and graft rejection.
  • Pre-clinical Animal Surgery Conduct surgey in animals used as pre-clinical models.
Show all 10 in Model Development 4 more
  • Pulmonary Hypertension Animal Model Study the pathology of pulmonary arterial hypertension (PAH) and investigate potential therapies.
  • SCID Mouse Use a single animal species to create one or more disease models for spontaneous and metastatic cancer and cachexia.
  • Surgical Models Create new animal models using techniques such as vascular catherization, soft tissue procedures or device implants.
  • Zucker Rat Use a single animal species to create one or more disease models for cachexia.

Neurotoxicology

  • Single Dose Acute Neurotoxicity Study - Other Species Conduct a single dose study in other species to determine the neurotoxicty of your compound.
  • Single Dose Acute Neurotoxicity Study - Rat Conduct a single dose study in rats to determine the neurotoxicty of your compound.

Non-Human Biospecimen

  • Guinea Pig Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
  • Guinea Pig Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
  • Mouse Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
  • Mouse Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
  • Rabbit Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
  • Rat Biofluids Acquire fresh or frozen biofluids including but not limited to whole blood, plasma, serum, CSF, milk, urine, feces, bile, semen, aqueous humor, vitreous humor, saliva, tears, etc.
Show all 8 in Non-Human Biospecimen 2 more
  • Rat Cells Acquire fresh or frozen cells including but not limited to RBCs, WBCs, PBMCs, endothelial cells, T cells, fibroblasts, hepatocytes, splenocytes, etc.
  • Rat Tissues Acquire fresh or frozen tissues including but not limited to those from the central nervous system, endocrine system, gastrointestinal system, integumentary system, reproductive system, lymphatic system, etc.

Oncology Models

  • Animal Hypoxia Models Measure therapeutic endpoints in hypoxic animal models.
  • CAR-T Efficacy In Vivo assessment of CAR-T and CAR-NK efficacy in a humanized mouse
  • Immuno-PDX Utilize the patient-derived xenograft for drug response profiling and biomarker discovery of immuno-oncology drug candidates.
  • Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.
  • Ovarian Cancer Mouse Measure therapeutic endpoints in animal models of ovarian cancer.

Pharmacology

  • In Vivo Pharmacology Study the effects of drug candidates in animal models

Protein Sciences

  • Cytokines Find recombinant cytokines or cytokine assays.
  • ELISA Detect the presence of antigens recognized by antibodies or find antibodies that recognize an antigen.
  • LCMS/MS Analysis Liquid chromatography–mass spectrometry is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography with the mass analysis capabilities of mass spectrometry.
  • Protein Binding Determine drug-protein binding interactions
  • Protein Services Consulting Expert advice to evaluate and analyze protein function and expression.
  • Qualitative MS Perform direct identification of molecules based on mass-to-charge ratio and fragmentation patterns.
Show all 7 in Protein Sciences 1 more
  • Quantitative MS Quantify small and large molecules in the pg/ml range

REACH Services

  • Ex Vivo REACH Assays Perform testing on cells or tissues cultured directly from a test organism
  • In Vivo REACH Services Performing testing when in vitro studies cannot be used to predict biological responses
  • OECD 407: Repeated Dose 28-day Oral Toxicity Study in Rodents This method provides information on health hazard likely to arise from exposure to test substance via oral administration.
  • OECD 420: Acute Oral Toxicity - Fixed Dose Procedure A principle of the method is that in the main study only moderately toxic doses are used, and the administration of doses that are expected to be lethal should be avoided. This Guideline is intended primarily for use...
  • OECD 423: Acute Oral toxicity - Acute Toxic Class Method The acute toxic class method set out in this Guideline is a stepwise procedure with the use of 3 animals of a single sex per step. Depending on the mortality and/or the moribund status of the animals, on average 2-4...
  • OECD 452: Chronic Toxicity Studies Evaluate the direct and indirect impact of prolonged and repeated toxin exposure to test organisms.

Safety Pharmacology

  • CNS Behavioral Measure safety toxicology effects of CNS and behavioral drugs.
  • Cytokine Release Syndrome In Vivo assessment of cytokine release syndrome liability in a humanized mouse
  • Neurotoxicity Study Study of the adverse effects of a substance on the brain or peripheral nervous system.

Scientific Data Services

  • Discovery Computational Systems Biology Model the interaction of biological system with drug candidates.
  • Systems Pharmacology Understand how drugs interact with different molecular and cellular systems within biological models.

Specialty Dosing Routes

  • Dermal Toxicology Assess toxicity in rodent dermal testing models.
  • Inhalation Toxicology Measure toxicity by daily clinical observation, body weight, clinical chemistry, hematology, and terminal necropsy and pathology.
  • Intra-Articular Toxicology Conduct a study to determine the toxicity and toxicokinetic behavior of your compound when delivered directly to the joint.
  • Intra-Auricular Toxicology Conduct a study to determine the toxicity and toxicokinetic behavior of your compound when delivered via the ear.
  • Intracameral Implant Toxicity and/or Toxicokinetic Study - Rabbit, Non-pigmented (New Zealand White; NZW) Conduct an intracameral implant toxicity study in non-pigmented rabbits to determine the toxicity and toxicokinetic behavior of your compound.
  • Intrathecal/Intraspinal Toxicology Conduct a study to determine the toxicity and toxicokinetic behavior of your compound when delivered via the intrathecal space.
Show all 18 in Specialty Dosing Routes 12 more
  • Repeat Dose Inhalation Study - Rat Conduct a repeat dose inhalation study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intranasal Study - Mouse Conduct a repeat dose intranasal study in mice to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intranasal Study - Rat Conduct a repeat dose intranasal study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intravenous Infusion Study - Other Species Conduct a repeat dose intravenous infusion study in other species to determine the toxicity and toxicokinetic behavior of your compound.
  • Repeat Dose Intravenous Infusion Study - Rats Conduct a repeat dose intravenous infusion study in rats to determine the toxicity and toxicokinetic behavior of your compound.
  • Single Dose Acute Inhalation Study - Rat Conduct a single dose inhalation study in rats to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intranasal Study - Mouse Conduct a single dose intranasal study in mice to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intranasal Study - Rat Conduct a single dose intranasal study in rats to determine the toxicokinetic behavior of your compound.
  • Single Dose Acute Intravenous Infusion Study - Rats Conduct a single dose intravenous infusion study in rats to determine the toxicokinetic behavior of your compound.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Mouse Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to mice.
  • Topical Dermal Toxicity and/or Toxicokinetic Study - Rat Conduct a dermal study to determine the toxicity and/or toxicokinetic behavior of your compound when applied topically to rats.
  • Topical Ocular Toxicity and/or Toxicokinetic Study - Minipig Conduct a topical ocular toxicity study in minipigs to determine the toxicity and toxicokinetic behavior of your compound.

Testing Services

  • In Vitro Skin Models Measure skin model penetration and invasion, photosensitivity and toxicity.

Other services

  • In Vivo Hollow Fiber Assay Evaluate test items concurrently with three different tumor cell lines within the same mouse.
  • New Request  

Service areas:

DMPK

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United Kingdom Hatfield, London 2 sites

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Pharmidex Pharmaceutical Services offers products for measuring the brain, microdialysis, ADMET, CNS solutions, and bioanalysis.

Website
www.pharmidex.com

Source: Scientist.com supplier network, written by the supplier

Get the Pharmidex Pharmaceutical Services report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Pharmidex Pharmaceutical Services on Scientist.com

For prices, more details, or to contact Pharmidex Pharmaceutical Services, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.